Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 22406595)

1.

Translational research. New findings and potential future applications in pancreatic adenocarcinoma.

Strimpakos AS, Syrigos KN, Saif MW.

JOP. 2012 Mar 10;13(2):177-9. Review.

2.

Pancreatic cancer: updates on translational research and future applications.

Sarris EG, Syrigos KN, Saif MW.

JOP. 2013 Mar 10;14(2):145-8. doi: 10.6092/1590-8577/1466. Review.

6.

Translational research in pancreatic adenocarcinoma.

Kaur G, Saif MW.

JOP. 2014 Mar 10;15(2):121-3. doi: 10.6092/1590-8577/2327.

7.

[Serum tumor markers at exocrine adenocarcinoma of pancreas].

Holubec L, Finek J, Topolcan O, Svobodová S.

Cas Lek Cesk. 2005;144(2):86-8; discussion 89. Review. Czech.

PMID:
15807292
9.
10.

Early detection of pancreatic cancer.

Eguia V, Gonda TA, Saif MW.

JOP. 2012 Mar 10;13(2):131-4. Review.

11.

New frontiers in pancreatic cancer research.

Khan GN, di Magliano MP, Simeone DM.

Surg Oncol Clin N Am. 2010 Apr;19(2):431-51. doi: 10.1016/j.soc.2009.11.010.

PMID:
20159524
12.

Novel targets for pancreatic cancer therapy.

Philip PA.

Surg Oncol Clin N Am. 2010 Apr;19(2):419-29. doi: 10.1016/j.soc.2009.11.012.

PMID:
20159523
13.

The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.

Jazieh KA, Foote MB, Diaz LA Jr.

Semin Radiat Oncol. 2014 Apr;24(2):67-76. doi: 10.1016/j.semradonc.2013.11.007. Review.

PMID:
24635863
14.

Pancreatic adenocarcinoma.

Howard TJ.

Curr Probl Cancer. 1996 Sep-Oct;20(5):281-328. Review.

PMID:
8902402
15.

Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.

Mazur PK, Siveke JT.

Gut. 2012 Oct;61(10):1488-500. doi: 10.1136/gutjnl-2011-300756. Epub 2011 Aug 26. Review.

PMID:
21873467
16.

[Pancreatic cancer that was diagnosed two years after palliative treatment].

Anía Lahuerta MA, Villalta Cabero J.

An Med Interna. 2006 Dec;23(12):585-7. Spanish.

PMID:
17371147
17.

Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology.

Märten A, Büchler MW, Werft W, Wente MN, Kirschfink M, Schmidt J.

J Immunother. 2010 Feb-Mar;33(2):219-24. doi: 10.1097/CJI.0b013e3181bed29f.

PMID:
20139773
18.

Locally advanced pancreatic adenocarcinoma: update and progress.

Ng J, Zhang C, Gidea-Addeo D, Saif MW.

JOP. 2012 Mar 10;13(2):155-8. Review.

19.

Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.

Fong D, Steurer M, Obrist P, Barbieri V, Margreiter R, Amberger A, Laimer K, Gastl G, Tzankov A, Spizzo G.

J Clin Pathol. 2008 Jan;61(1):31-5. Epub 2006 Jun 14.

PMID:
16775119
20.

[Pancreatic adenocarcinoma: therapeutical update].

Khosravi Shahi P, Díaz Muñoz de la Espada VM.

An Med Interna. 2005 Aug;22(8):390-4. Review. Spanish.

PMID:
16351494
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk